15.12.2010
- French drugmaker Sanofi-Aventis is in talks to invest in Hadasit Bio-Holdings, the Israeli biotech holding company said on Tuesday. Hadasit said the potential investment would be...
14.12.2010
- Sanofi-Aventis named Elias Zerhouni as its new head of research and development as the French drugmaker reshapes its drug portfolio to offset sales losses from patent expiries...
13.12.2010
- Sanofi-Aventis has extended its snubbed $18.5 billion cash bid for U.S. biotech group Genzyme by six weeks, buying the French drugmaker time to persuade its reluctant target to...
06.12.2010
- EU anti-trust regulators have carried out raids on some firms in the pharmaceutical sector on suspicions of collusion to delay the entry of generic drugs into the market, the...
06.12.2010
- Genzyme shareholder and board member Ralph Whitworth said the "ingredients are there" for a deal with Sanofi-Aventis , but the French drugmaker's $69-a-share offer is "not even a...
02.12.2010
- Sanofi-Aventis's CFO said a deal structure known as a contingent value right was interesting "in principle" but he declined to say if it was being discussed with bid target Genzyme...
30.11.2010
- Genzyme, resisting a hostile bid from Sanofi-Aventis, is open to a deal that links its value to the success of key drug Campath, the U.S. biotech's chief executive was quoted as...
25.11.2010
- Genzyme Corp has met the first in a series of deadlines imposed by U.S. regulators for fixing problems at its Boston plant, a milestone that could bolster the biotech company's...
